 | • レポートコード：D0-MOR-AP0217 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、細胞カウントの世界市場について調査・分析した資料で、細胞カウントの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Cell Counting market studied was projected to grow with a CAGR of 6.6% over the forecast period. The major factor attributing to the growth of the market is the rising incidence of target diseases like HIV, measles, Diphtheria and chronic diseases like cancer, and other blood disorders.
According to the World Health Organization (WHO), it is estimated that in 2018, nearly 37.9 million individuals had HIV, globally. It has been identified that most of this prevalence is in low and middle-income countries, with an estimated 66% living in Sub-Saharan Africa. As per a report by Meryem Jefferies et al. published in the World Journal of Clinical Cases 2018, every year 1.4 million people die from viral hepatitis-related cirrhosis and liver cancer. Thus, rising cases of infectious diseases are ultimately expected to increase the demand for cell counting market.
Key Market Trends
Instruments Segment is Expected To Dominate the Market
The dominant share of the segment is attributed to the increasing usage of the cell counters in various applications like research, diagnostics, and industrial. Cell counting instruments are increasingly being adopted in various areas of research such as cancer biology, immunology, and neuroscience, which displays exponential growth opportunities for the market. Increasing chronic diseases increases the demand for the instruments.
According to UNAIDS, 37.9 million people globally were affected with HIV, 1.7 million became newly infected with HIV, 770 000 people died from AIDS-related illnesses by the end of 2018. The increasing patient pool and increasing research and development propel the market growth
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall Cell Counting market, throughout the forecast period. The largest share is mainly due to the presence of a larger patient pool and increasing geriatric population. In the North America region, the United States holds the largest market share due to factors such as the increasing number of chronic diseases, along with a growing number of research and development programs in the country. According to the latest estimates from the Centers for Disease Control and Prevention, 37,832 people received an HIV diagnosis in the United States, in 2018. As per the statistics the large patient pool and high disposable income propels the market growth in the region.
Competitive Landscape
The Cell Counting market is moderately competitive. A few of the crucial approaches followed by players are product advancement, invention, acquisitions, and mergers. Some of the companies currently dominating the market are Beckman Coulter, Inc., Thermo Fisher Scientific, Becton, Dickinson and Company, Merck, Bio-Rad Laboratories, Ge Healthcare.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Incidence of Target Diseases and Blood Disorders
4.2.2 Growing Use of High-Throughput Flow Cytometry and Automated Hematology Analyzers
4.3 Market Restraints
4.3.1 High Cost of Advanced Cell Counting Systems and Product Recalls of Hematology Analyzers
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Instruments
5.1.1.1 Spectrophotometers
5.1.1.2 Flow Cytometers
5.1.1.3 Hematology Analyzers
5.1.1.4 Cell Counters
5.1.2 Consumables
5.1.2.1 Media, Sera, and Reagents
5.1.2.2 Assay Kits
5.1.2.3 Others
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Beckman Coulter, Inc.
6.1.2 Thermo Fisher Scientific
6.1.3 Becton, Dickinson and Company
6.1.4 Merck
6.1.5 Bio-Rad Laboratories
6.1.6 Ge Healthcare
6.1.7 Agilent Technologies
6.1.8 F. Hoffmann-La Roche
6.1.9 Siemens Healthineers
6.1.10 Biotek Instruments
7 MARKET OPPORTUNITIES AND FUTURE TRENDS